In addition, the validation COVID-19 cohort in comparison to influenza-infected subjects exhibited significantly lower levels of IL-1β, IL-4, IP-10, TNFα, IL-1α, IL-17f, fibroblast growth factor (FGF), and eotaxin (Fig. 3, B and C, and figs. This evidence concerns the gene CXCL10 and COVID-19.